Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Patient dose" patented technology

Variable incident ray angle ray attenuation system on-axis collimation arrangement and ct apparatus

PendingCN122296936AImaging qualityCt imaging
This application relates to the field of CT imaging technology. A collimation device on a variable incident light angle X-ray attenuation system includes: a X-ray filter; an A-level collimator disposed at the incident end of the X-ray filter; and a B-level collimator disposed at the exit end of the X-ray filter. The opening centers of the A-level and B-level collimators are symmetrically arranged along the perpendicular bisector of the imaging field range perpendicular to the light plane, based on the X-ray source focal spot, to compensate for X-ray divergence deviation caused by the X-ray source focal spot and limit the X-ray incident width. While ensuring CT scan imaging quality, this application achieves the dual technical effects of improved X-ray utilization efficiency and reduced patient dose, effectively solving a series of scattering-related technical problems associated with traditional X-ray filtering devices alone.
Owner:SINOVISION MEDICAL TECH (YANGZHOU) CO LTD

Therapeutic zone assessor

Systems and methods are provided for identifying therapeutic zones where there is glycemic dysfunction of a specific type that can be addressed by making strategic changes to behavior and / or therapy parameters. Systems and methods described herein evaluate large historical data sets to: identify a therapeutic zone or zones with glycemic dysfunction that are most readily addressable; quantify the glycemic impact of a plurality of different therapeutic adjustments in terms of either adjustments to historical doses or the parameters of a prospective dosing strategy to determine the highest possible improvement; and / or identify patient dosing strategies to provide therapy recommendations adapted for the patient's preferred behavioral dosing strategy.
Owner:DEXCOM INC